In the Drosophila germ line, PIWI-interacting RNAs (piRNAs) ensure genomic stability by silencing endogenous selfish genetic elements such as retrotransposons and repetitive sequences. We examined the genetic requirements for the biogenesis and function of piRNAs in both female and male germ line. We found that piRNAs function through the PIWI, rather than the AGO, family Argonaute proteins, and the production of piRNAs requires neither microRNA (miRNA) nor small interfering RNA (siRNA) pathway machinery. These findings allowed the discovery of the third conserved small RNA silencing pathway, which is distinct from both the miRNA and RNAi pathways in its mechanisms of biogenesis and function. We also found piRNAs in flies are modified. We determined that the chemical structure of the 3´-terminal modification is a 2´-O-methyl group, and also demonstrated that the same modification occurs on the 3´ termini of siRNAs in flies. Furthermore, we identified the RNA methyltransferase Drosophila Hen1, which catalyzes 2´-O-methylation on both siRNAs and piRNAs. Our data suggest that 2´-O-methylation by Hen1 is the final step of biogenesis of both the siRNA pathway and piRNA pathway. Studies from the Hannon Lab and the Siomi Lab suggest a ping-pong amplification loop for piRNA biogenesis and function in the Drosophila germline. In this model, an antisense piRNA, bound to Aubergine or Piwi, triggers production of a sense piRNA bound to the PIWI protein Argonaute3 (Ago3). In turn, the new piRNA is envisioned to produce a second antisense piRNA. We isolated the loss-of-function mutations in ago3, allowing a direct genetic test of this model. We found that Ago3 acts to amplify piRNA pools and to enforce on them an antisense bias, increasing the number of piRNAs that can act to silence transposons. Moreover, we also discovered a second Ago3-independent piRNA pathway in somatic ovarian follicle cells, suggesting a role for piRNAs beyond the germ line.

Un contexte réglementaire de plus en plus strict dans le domaine de l’évaluation environnementale de l’impact des composés chimiques d’origine anthropique et plus précisément du risque écotoxicologique dans l’environnement aquatique, exige de renforcer les outils d’évaluation et d’affiner la connaissance de leur valeur prédictive. A ce titre, l’étude des biomarqueurs de génotoxicité doit être privilégiée, compte tenu du rôle central de l’ADN dans le fonctionnement du vivant et des effets trans-générationnels susceptibles de conduire à un fardeau génétique affectant les populations exposées à un environnement contaminé. Dans cette perspective, et après avoir défini la problématique à l’issue d’une analyse bibliographique, ce travail de thèse a permis de développer un biomarqueur de génotoxicité chez l’épinoche (Gasterosteus aculeatus), espèce modèle en écotoxicologie, en utilisant la mesure des dommages primaires à l’ADN par le test des comètes en conditions alcalines. Il visait à : i) apporter une information complémentaire au sein d’une batterie de biomarqueurs utilisée en biomonitoring chez cette espèce, 2) apporter des éléments de compréhension sur la valeur prédictive d’un effet génotoxique sur le tissu germinal des organismes aquatiques exposés au stress chimique. Concernant le premier point, les résultats soulignent l’intérêt de ce biomarqueur de génotoxicité développé sur le tissu sanguin au laboratoire, sa grande sensibilité amenant à un pouvoir discriminant significatif dans le cadre d’approches multiparamétriques menées dans un second temps sur le terrain. Pour ce qui est de l’étude de la signification écotoxicologique de ce biomarqueur de génotoxicité, le but était d’explorer le lien entre l’intégrité de l’ADN des cellules germinales de ce poisson et la qualité de la descendance. Les résultats de ce travail démontrent de manière originale la contribution majoritaire du génome paternel à la transmission d’une information génétique délétère ayant pour conséquence des anomalies de survie et de développement mesurées sur la descendance. Ils permettent de disposer d’un élément d’évaluation prédictive pertinent de l’effet des contaminants à potentiel génotoxique dans les écosystèmes aquatiques, dans un contexte d’intérêt grandissant de la compréhension du déclin de populations de poisson universellement recensé. / A rule context in the field of environmental impact assessment of anthropogenic chemicals and specifically ecotoxicological risk to the aquatic environment, requires strengthening the assessment tools and refine knowledge of their predictive value. As such, the study of biomarkers of genotoxicity should be choose, given the central role of DNA in living organisms function and trans-generational effects could lead to a genetic load affecting populations exposed to a contaminated environment . In this context, and after defining the problem at the end of a literature review, this thesis has developed a biomarker of genotoxicity in the stickleback (Gasterosteus aculeatus), model species in ecotoxicology, using the measurement primary DNA damage by the comet assay under alkaline conditions. It aimed to: i) provide additional information in a battery of biomarkers used in biomonitoring in this species, 2) provide some understanding of the predictive value of a genotoxic effect on the germinal tissue of aquatic organisms exposed to chemical stress. On the first point, the results underline the importance of this biomarker of genotoxicity developed on blood tissue in the laboratory, its high sensitivity leading to a significant discriminating power under multiparameter approaches taken in a second time on the ground. Regarding the study of the ecotoxicological significance of this biomarker of genotoxicity, the aim was to explore the relationship between DNA integrity in germ cells of the fish and the quality of the offspring. The results of this work show an original way the majority of the paternal genome contribution to the transmission of a deleterious genetic information that result in abnormal survival and development measured on the offspring. They allow you to have a predictive element relevant evaluation of the effect of genotoxic potential contaminants in aquatic ecosystems, in a context of growing interest in understanding the decline of fish populations identified universally.

Diversos genes expressos durante a diferenciação das células germinativas atuam no desenvolvimento ovariano. A diferenciação das células somáticas ovarianas depende do número de células germinativas pré-meióticas que migram para a fenda gonadal. A expressão espaço-temporal de genes envolvidos na diferenciação dessas células e a posterior sobrevivência dos oócitos meióticos são de interesse no estudo dos distúrbios do desenvolvimento sexual (DDS) 46,XX. Entre os genes envolvidos nesses processos estão o NANOS3, BMP15 e STRA8. O NANOS3, uma molécula de ligação ao RNA que bloqueia a via apoptótica, assegura a sobrevivência das células germinativas durante sua migração para o interior da gônada. O STRA8 atua no início da meiose das células germinativas na gônada de embriões XX, sendo o primeiro sinal de dimorfismo gonadal. Por outro lado a subseqüente sobrevivência dos oócitos é controlada por fatores de transformação e crescimento como o BMP15, que promove a diferenciação das células da granulosa que por sua vez participam indiretamente da diferenciação dos oócitos e das células da teca. Neste trabalho pesquisamos a presença de mutações inativadoras nos genes NANOS3 e BMP15 em 45 pacientes com disgenesia gonadal (DG) 46,XX (10 casos familiais) e 40 pacientes com amenorréia secundária sem mutação nos genes FSHR e SF1. Também pesquisamos mutações nas regiões promotora proximal e codificadora do gene STRA8 de 45 pacientes com DG 46,XX, 16 pacientes com DDS ovotesticular 46,XX e 5 pacientes com DDS testicular 46,XX todos SRY negativo nos quais foram afastados defeitos moleculares nos genes DAX1, WNT4 e SOX9. No NANOS3 identificamos a mutação p.E120K em homozigose, a primeira associada ao fenótipo de DG 46,XX. Esta mutação missense foi identificada em duas irmãs com DG 46, XX e está localizada no domínio de ligação do tipo dedo de zinco da proteína. A nova mutação não foi identificada em 200 alelos controles pesquisados. No BMP15, uma nova mutação nonsense p.Q115X foi identificada em homozigose em duas irmãs com DG 46XX e em heterozigose em uma paciente com amenorréia secundária não familial. O códon de parada prematuro está localizado na região do pré-peptídeo da proteína. A nova mutação não foi identificada em 200 alelos controles pesquisados. No gene STRA8, um único polimorfismo previamente descrito na literatura (rs7805859) foi identificado na região codificadora e nenhuma alteração na região promotora proximal foi identificada. Em conclusão, identificamos pela primeira vez uma mutação no gene NANOS3 associado á DG 46,XX e confirmamos a participação do BMP15 neste fenótipo. Distúrbios do desenvolvimento gonadal 46, XX podem ser causados por mutações em genes envolvidos tanto na diferenciação quanto manutenção das células germinativas ovarianas. / Several genes expressing during the germ cell differentiation act in ovary development. The differentiation of somatic ovary cells depends of a pool of pre meiotic germ cells migration into the gonad. The space and temporal expression pattern of some genes involved with germ cell differentiation and the subsequently oocyte survival should be investigated in the disorders of sexual development (DSD) 46,XX. Some key genes involved with these processes are: NANOS3, BMP15 and STRA8. The NANOS3, a RNA binding molecule that blocks the apoptotic pathway, ensures the survival during migration into genital ridge. The STRA8 acts in the bigining of germ cells meioses in XX embryos and mark the first sexual gonadal dimorphism. In other hand the subsequently oocyte survival is controlled through transforming growth factor member BMP15, that guarantees granulose cells differentiation that acts indirectly in meiotic oocyte and theca cells differentiation. In this work we searched for the presence of inactivating mutations in NANOS3 and BMP15 in 45 patients with 46XX gonadal dysgenesis (10 familial cases) and 40 patients with secondary amenorrhea without FSHR and SF1 mutation. We also searched for inactivating mutations in coding and proximal promoter region of STRA8 in 45 patients with 46XX gonadal dysgenesis, 16 ovotesticular disorder of sex development (DSD) patients and five 46XX testicular DSD patients all SRY negative and molecular defects in DAX1, WNT4 and SOX9 gene. In NANOS3 we identified the mutation p.E120K in homozygous state, the first associated with DG 46,XX phenotype. This missense mutation was identified in two sisters with 46XX GD and affects a zinc finger domain of the protein. The new variant was absent in 200 control alleles. In BMP15, a new nonsense mutation p.Q115X was identified two sisters in homozygous state and in one sporadic case of secondary amenorrhea in heterozygous state. The premature codon STOP affects the pro-peptide domain of the protein. The new variant was absent in 200 control alleles. In STRA8, only a previously described polymorphism (rs7805859) was identified without any other variation in coding or proximal promoter region. In conclusion, we identified for the fist time mutation in NANOS3 associated with DG 46XX and corroborate the role of BMP15 in this phenotype. Disorders of gonadal development 46,XX may be involved with differentiation and maintenance of ovarian germ cells.

Diversos genes expressos durante a diferenciação das células germinativas atuam no desenvolvimento ovariano. A diferenciação das células somáticas ovarianas depende do número de células germinativas pré-meióticas que migram para a fenda gonadal. A expressão espaço-temporal de genes envolvidos na diferenciação dessas células e a posterior sobrevivência dos oócitos meióticos são de interesse no estudo dos distúrbios do desenvolvimento sexual (DDS) 46,XX. Entre os genes envolvidos nesses processos estão o NANOS3, BMP15 e STRA8. O NANOS3, uma molécula de ligação ao RNA que bloqueia a via apoptótica, assegura a sobrevivência das células germinativas durante sua migração para o interior da gônada. O STRA8 atua no início da meiose das células germinativas na gônada de embriões XX, sendo o primeiro sinal de dimorfismo gonadal. Por outro lado a subseqüente sobrevivência dos oócitos é controlada por fatores de transformação e crescimento como o BMP15, que promove a diferenciação das células da granulosa que por sua vez participam indiretamente da diferenciação dos oócitos e das células da teca. Neste trabalho pesquisamos a presença de mutações inativadoras nos genes NANOS3 e BMP15 em 45 pacientes com disgenesia gonadal (DG) 46,XX (10 casos familiais) e 40 pacientes com amenorréia secundária sem mutação nos genes FSHR e SF1. Também pesquisamos mutações nas regiões promotora proximal e codificadora do gene STRA8 de 45 pacientes com DG 46,XX, 16 pacientes com DDS ovotesticular 46,XX e 5 pacientes com DDS testicular 46,XX todos SRY negativo nos quais foram afastados defeitos moleculares nos genes DAX1, WNT4 e SOX9. No NANOS3 identificamos a mutação p.E120K em homozigose, a primeira associada ao fenótipo de DG 46,XX. Esta mutação missense foi identificada em duas irmãs com DG 46, XX e está localizada no domínio de ligação do tipo dedo de zinco da proteína. A nova mutação não foi identificada em 200 alelos controles pesquisados. No BMP15, uma nova mutação nonsense p.Q115X foi identificada em homozigose em duas irmãs com DG 46XX e em heterozigose em uma paciente com amenorréia secundária não familial. O códon de parada prematuro está localizado na região do pré-peptídeo da proteína. A nova mutação não foi identificada em 200 alelos controles pesquisados. No gene STRA8, um único polimorfismo previamente descrito na literatura (rs7805859) foi identificado na região codificadora e nenhuma alteração na região promotora proximal foi identificada. Em conclusão, identificamos pela primeira vez uma mutação no gene NANOS3 associado á DG 46,XX e confirmamos a participação do BMP15 neste fenótipo. Distúrbios do desenvolvimento gonadal 46, XX podem ser causados por mutações em genes envolvidos tanto na diferenciação quanto manutenção das células germinativas ovarianas. / Several genes expressing during the germ cell differentiation act in ovary development. The differentiation of somatic ovary cells depends of a pool of pre meiotic germ cells migration into the gonad. The space and temporal expression pattern of some genes involved with germ cell differentiation and the subsequently oocyte survival should be investigated in the disorders of sexual development (DSD) 46,XX. Some key genes involved with these processes are: NANOS3, BMP15 and STRA8. The NANOS3, a RNA binding molecule that blocks the apoptotic pathway, ensures the survival during migration into genital ridge. The STRA8 acts in the bigining of germ cells meioses in XX embryos and mark the first sexual gonadal dimorphism. In other hand the subsequently oocyte survival is controlled through transforming growth factor member BMP15, that guarantees granulose cells differentiation that acts indirectly in meiotic oocyte and theca cells differentiation. In this work we searched for the presence of inactivating mutations in NANOS3 and BMP15 in 45 patients with 46XX gonadal dysgenesis (10 familial cases) and 40 patients with secondary amenorrhea without FSHR and SF1 mutation. We also searched for inactivating mutations in coding and proximal promoter region of STRA8 in 45 patients with 46XX gonadal dysgenesis, 16 ovotesticular disorder of sex development (DSD) patients and five 46XX testicular DSD patients all SRY negative and molecular defects in DAX1, WNT4 and SOX9 gene. In NANOS3 we identified the mutation p.E120K in homozygous state, the first associated with DG 46,XX phenotype. This missense mutation was identified in two sisters with 46XX GD and affects a zinc finger domain of the protein. The new variant was absent in 200 control alleles. In BMP15, a new nonsense mutation p.Q115X was identified two sisters in homozygous state and in one sporadic case of secondary amenorrhea in heterozygous state. The premature codon STOP affects the pro-peptide domain of the protein. The new variant was absent in 200 control alleles. In STRA8, only a previously described polymorphism (rs7805859) was identified without any other variation in coding or proximal promoter region. In conclusion, we identified for the fist time mutation in NANOS3 associated with DG 46XX and corroborate the role of BMP15 in this phenotype. Disorders of gonadal development 46,XX may be involved with differentiation and maintenance of ovarian germ cells.

Reproductive containment in farmed fish is highly desired for sustainable aquaculture to prevent genetic introgression with wild conspecifics and enhance productivity by suppressing sexual maturation. A number of strategies have already been implemented or have been tested in commercially important fish (e.g. triploidy, monosexing, hormonal therapies); however, they either do not result in 100% containment, or they cannot be applied to all species. One promising new approach consists in disrupting primordial germ cells (PGCs), at the origin of germline cells, to induce sterility. The work carried out in this doctoral thesis aimed to investigate the genes involved in the survival of germ cells and subsequently conduct a functional analysis of candidate genes using CRISPR/Cas9 gene editing system to ultimately provide the basis for the development of a novel sterilisation technique. Nile tilapia was chosen as the experimental animal as it is a major aquaculture species worldwide and the control of reproduction plays a critical role in the farming productivity in this species. In addition, the species has clear advantages as its whole genome sequence is accessible, the generation time is relatively short and zygotes can be available all year round. Initially, a panel of 11 candidate genes with reported roles in survival of PGCs was investigated during the ontogenic development which led to the selection of piwi-like (piwil) gene as a target for genome editing. Then, high temperature was tested as a means to induce germ cell loss to better understand the mechanism underlying germ cell survival and apoptosis, and this study confirmed the functional importance of piwil genes in relation to germ cell loss and proliferation. In addition, the study suggested potential subfunctionalisation within the Bcl-2 gene family which requires further investigation. The next step aimed to optimise the CRISPR/Cas9 gene editing method by improving the microinjection system and testing different concentrations of sgRNAs. Over 95% of injected embryos showed on-target mutation in piwil2 via zygote injection of CRISPR/Cas9 reagents and complete KO larvae were shown in half of the mutants, producing putative sterile fish. However, there was no clear association between the phenotypes in PGCs and the mutation rate. Further comparative studies of mutant screening methods including T7E1, RGEN, HRMA, fragment analysis and NGS revealed that the genotypes of F0 are highly mosaic, suggesting that deep sequencing is recommended for accurate and high throughput F0 screening and further improvement for predictable genome editing is required for a reliable gene functional analysis in F0. In summary, the current thesis provided new scientific knowledge and supporting evidence for the use of the CRISPR/Cas9 gene editing platform to study gene function associated with sterility, with the ultimate goal to develop an alternative sterilisation method in fish.

Un certain nombre d’études épidémiologiques ont montré au cours des cinquante dernières années une augmentation des infertilités, des malformations de l’appareil reproducteur masculin et des cancers testiculaires. Une des hypothèses est que, l’exposition durant la vie foetale ou néonatale à des composés présents dans l’environnement capables d’interférer avec le système hormonal (perturbateurs endocriniens), serait responsable de l’augmentation de l’incidence de ces pathologies. Les molécules qui sont suspectées d’avoir des effets néfastes à long terme sur le tractus génital mâle possèdent des activités de type estrogénique ou antiandrogénique. Parmi les mécanismes impliqués dans l’effet à long terme, un certain nombre d’auteurs mettent en avant l’intervention de mécanismes de type épigénétiques. Dans ce contexte, nous avons utilisé deux types de modèles expérimentaux reposant sur l’exposition développementale de rats à ces composés : un modèle d’exposition néonatale à un estrogène (estradiol benzoate) et un modèle d’exposition foetale à un antiandrogène (flutamide). Les deux modèles expérimentaux induisent chez le rongeur un phénotype d’hypospermatogenèse. Dans le cas de l’exposition néonatale à l’estradiol benzoate nous montrons que l’hypospermatogenèse observée chez les animaux à l’âge adulte est due à l’activation chronique de l’apoptose des cellules germinales testiculaires. Cette apoptose mettrait en jeu, par un mécanisme post-transcriptionnel, la diminution à long terme de l’expression de protéines clés de la machinerie épigénétique de méthylation de l’ADN, les ADN méthyltransférases (DNMT 3A, 3B et 1), et du facteur antiapoptotique, MCL-1. D’un point de vue fonctionnel, la chute d’expression des DNMTs se traduit notamment par l’augmentation d’expression des éléments transposables LINE-1 et du gène Ibtk normalement contrôlés par méthylation de l’ADN. En amont, la chute d’expression des DNMTs et de MCL-1 serait dépendante de l’augmentation d’expression d’autres effecteurs épigénétiques, les microRNAs de la famille miR-29. Dans le cas de l’exposition in utero au flutamide, notre travail indique que l’apoptose chronique des cellules germinales serait liée à la diminution à long terme de l’expression des inhibiteurs d’apoptose cIAP1 et cIAP2, et une augmentation d’expression de leur inhibiteur SMAC/DIABLO. En revanche, l’absence de mort des cellules somatiques testiculaires (Sertoli et Leydig) dans ce modèle serait due à l’augmentation d’expression spécifiquement dans ces cellules des inhibiteurs d’apoptose XIAP et SURVIVIN. Par ailleurs, le phénotype d’apoptose observé à l’âge adulte impliquerait également une altération précoce de l’expression des DNMTs. En conclusion, nous apportons une réponse mécanistique au phénotype de programmation foetale/néonatale d’apoptose des cellules germinales testiculaires adultes. En effet, l’augmentation des miR-29s provoquerait : (1) une chute d’expression des DNMTs altérant ainsi le profil de méthylation des gènes, et (2) une chute d’expression de facteurs protégeant les cellules germinales contre l’apoptose comme le facteur MCL-1. / During the five past decades, a number of epidemiological studies have indicated a higher incidence of infertility problems, male reproductive tract abnormalities and testicular cancers. Among the different hypotheses proposed, fetal or neonatal exposure to environmental compounds that can interfere with endocrine system, termed endocrine disruptors, may be at the origin of the rising incidence of these diseases. The molecules that are supposed to have long term adverse effects on the male genital tract have estrogenic or antiandrogenic properties. Some authors have suggested that the long term effects of endocrine disruptors could be mediated through epigenetic mechanisms. In this context, we have used two types of experimental models based on developmental exposure to these compounds: one model of neonatal exposure to an estrogen (estradiol benzoate) and another model of fetal exposure to an antiandrogen (flutamide). The two experimental models induce a phenotype of hypospermatogenesis in rodents. In the context of neonatal exposure to estradiol benzoate we show that the hypospermatogenesis observed in adult animals is the consequence of a chronic activation of the apoptotic process of testicular germ cells. This cell death process seem to involve the decrease of the key epigenetic effectors of DNA methylation machinery DNA methyltransferases (DNMT3A, 3B & 1), and of the antiapoptotic protein MCL-1 through post transcriptional mechanisms. In term of functional consequences the decrease of DNMTs proteins leads to increased expression of transposable element LINE-1 and Ibtk gene that are normally controlled by DNA methylation. Upstream DNMTs and MCL-1 decrease may be triggered by the increase of other epigenetic factors, the microRNAs belonging to miR-29 family. Concerning in utero exposure to flutamide, our work indicate that the chronic apoptotic process of germ cells may be linked to long term decrease of the inhibitors of apoptosis cIAP1 & 2, and an increase of proapoptotic factors SMAC/DIABLO. On the other hand, the lack of testicular somatic cell death in this model may be the result of higher expression of inhibitors of apoptosis XIAP and SURVIVIN in these cells. Besides, the apoptotic process observed at the adult age may also involve a precocious alteration of DNMTs expression. In summary, our work provides a mechanistic view to the fetal/neonatal programming of adult germ cell death. Indeed, the increased levels of miR-29s may induce: (1) a decrease in DNMTs expression levels that consequently could alter the methylation pattern of some genes, and (2) a decrease in factors that normally prevent germ cells death such as MCL-1.

Un certain nombre d’études épidémiologiques font état d’une augmentation de l’infertilité masculine durant ces cinquante dernières années, en particulier dans les pays industrialisés, mais aussi d’une augmentation des malformations de l’appareil reproducteur masculin telles que la cryptorchidie (absence de migration des testicules dans les bourses) ou l’hypospadias (malformation du pénis), et des cancers testiculaires. Des données expérimentales suggèrent que ces anomalies du tractus génital mâle sont liées. Ces symptômes forment le syndrome de dysgénésie testiculaire. Les causes d’apparition ce syndrome semblent être d’origine environnementale. En effet, les évolutions relativement rapides de ce syndrome suggèrent des facteurs dynamiques, en lien avec le mode de vie ou l’environnement. Une des hypothèses est que, l’exposition durant la vie fœtale ou néonatale à des composés présents dans l’environnement capables d’interférer avec le système hormonal (perturbateurs endocriniens environnementaux, PEEs), serait responsable de l’augmentation de l’incidence de ces pathologies. Au banc des principaux accusés, les molécules qui possèdent des activités de type estrogénique ou antiandrogénique. A ce jour, les mécanismes d’action à l’origine du syndrome de dysgénésie testiculaire sont encore mal connus. Certaines études suggèrent des mécanismes de type épigenétique dans les effets à long terme des PEEs. L’objectif de notre travail était d’identifier et caractériser les mécanismes d’action de type épigenétique impliqué dans l’infertilité mâle. Pour cela, nous avons utilisé un modèle expérimental (rats nouveau-nés) reposant sur une exposition développementale à un estrogène (estradiol benzoate). Ce modèle induit chez le rat adulte un phénotype d’hypospermatogenèse liée à une à apoptose chronique des cellules germinales testiculaires. Nous montrons que ce phénotype est lié à l’altération de deux voies, impliquant en amont des effecteurs épigénétiques. La première voie implique la famille des miR-29s. Ainsi, nous observons une augmentation de l’expression des miR-29a, b, c qui provoque une diminution de deux de ses cibles: la protéine antiapoptotique MCL-1 et les enzymes de méthylation de l’ADN DNMTs. La chute des DNMTs entraine une hypométhylation globale (estimée à travers le gène Line-1) et spécifique du facteur de choc thermique HSF1. Ceci provoque une réexpression de ces facteurs entrainant l’apoptose des cellules germinales adultes. La deuxième voie implique le miR-18a. L’augmentation de son expression provoque une chute de l’expression de sa cible HSF2 qui régule la protéine de choc thermique HSP70/HSPA2. Le faible taux d’HSPA2 est une autre explication de l’apoptose des cellules germinales dans notre modèle. Nous montrons aussi que ce phénotype est irréversible lorsque l’exposition à lieu chez le nouveau-né alors qu’il est réversible quand l’exposition à lieu à l’âge adulte. Ces données suggèrent que l’exposition néonatale à l’estradiol benzoate induit une programmation développementale de l’hypospermatogenèse.Enfin, les anomalies tissulaires d’expression des miRNAs se retrouvent au niveau sanguin, suggérant leur utilisation potentielle comme biomarqueurs. Nous avons validé cet aspect chez l’homme en montrant que l’expression des miR29s et du miR-18a était plus élevée chez les patients oligo- ou azoospermiques que les chez patients normospermiques.En conclusion, nos résultats indiquent que l’hypospermatogenèse due à une apoptose chronique des cellules germinales observée chez l’animal adulte après exposition néonatale à l’EB met en jeu une modification d’expression de plusieurs effecteurs épigénétiques clés: miR-29s, miR-18a et DNMTs. De plus, les miR-29s et miR-18a pourraient être de nouveaux biomarqueurs circulants non invasifs de la stérilité masculine dans le contexte d’une oligo ou azoospermie chez l'homme. / Epidemiological studies have reported an increase in male infertility over the past fifty years, especially in industrialized countries, but also an increase in malformations of the male reproductive tract such as cryptorchidism (no migration of the testes into the scrotum) and hypospadias (malformation of the penis), and testicular cancers. Experimental data suggest that these abnormalities of the male genital tract are related. These symptoms form the testicular dysgenesis syndrome. The causes of the occurrence of this syndrome appear to be environmental in origin. Indeed, the relatively rapid evolution of this syndrome suggests dynamic factors related to lifestyle or environment. One hypothesis is that exposure during fetal or neonatal life to compounds present in the environment can interfere with the hormonal system (environmental endocrine disruptors), would be responsible for the increased incidence of these pathologies. Bench of the main accused, molecules that have estrogenic or anti-androgenic activity types. To date, the mechanisms of action behind the testicular dysgenesis syndrome are poorly understood. Some studies suggest that epigenetic mechanisms are at playThe objective of our work was to identify and characterize the epigenetic mechanisms of action involved in male infertility induced by neonatal exposure to xenoestrogen. For this, we used an experimental model based on a developmental exposure to estrogen (estradiol benzoate). This model induced in adult rats a hypospermatogenesis phenotype due to chronic apoptosis of germ cells.We show that this phenotype is related to an alteration of two pathways, involving upstream effectors epigenetic. The first pathway involves the family of miR- 29s. Thus, we observe an up-regulation of miR -29a, b, c, which causes a decrease in two of his targets: the anti-apoptotic protein MCL- 1 and the enzymes of DNA methylation DNMTs. Falling DNMTs leads to a global hypomethylation (estimated through the Line -1 gene) and to specific hypomethylation of the heat shock factor, HSF1. This causes a re-expression of factors that induce apoptosis in adult germ cells. The second pathway involves up-regulation of miR -18a that causes a down-regulation of its target HSF2 which regulates the heat shock protein HSP70/HSPA2. The down-regulation of HSPA2 is another explanation of germ cell apoptosis in our model. We also show that this phenotype is irreversible when the estrogen exposure takes place in the newborn whereas it is reversible when exposure takes place in adulthood, suggesting that neonatal exposure to estradiol benzoate induced a developmental programming of hypospermatogenesis.Finally, abnormal tissue expressions of miRNAs are found in the blood, suggesting their potential use as biomarkers. We validated this aspect in humans showing that the expression of miR29s and miR-18a was higher in patients with decrease or no sperm counts compared to normal sperm count. In conclusion, our results indicate that hypospermatogenesis due to chronic germ cell apoptosis observed in adult animals after neonatal exposure to EB involves a change in expression of several key epigenetic effectors: miR-29, miR-18a and DNMTs. In addition, miR-29 and miR-18a could be new non invasive circulating biomarkers of men infertility.

Pluripotent stem cells (PSCs) are specialized cells, which have remarkable ability to maintain in an undifferentiated state and are capable of undergoing differentiation to three germ-layer lineage cell types, under differentiation-enabling conditions. PSCs include embryonic stem (ES)-cells, embryonal carcinoma (EC)-cells and embryonic germ (EG)-cells. ES-cells are derived from the inner cell mass (ICM) of day 3.5 blastocysts (mouse). On the other hand, EC- and EG-cells have different source of origin and exhibit some differences in terms of their differentiation abilities and culture requirements. These PSCs act as an ideal in-vitro model system to study early mammalian development and cell differentiation and, they could potentially be used for experimental cell-based therapy for a number of diseases. However, one of the problems encountered is the immune rejection of transplanted cells. For this, immune-matched induced pluripotent stem (iPS)-cells have been derived from somatic cells, by forced expression of a few stemness genes. Although, human PSCs lines are being experimented, their cell-therapeutic potential is still far from being thoroughly tested due to lack of our understanding regarding lineage-specific differentiation, homing and structural-functional integration of differentiated cell types in the host environment. To understand these mechanisms, it is desirable to have fluorescently-marked PSCs and their differentiated cell-types, which could facilitate experimental cell transplantation studies. In this regard, our laboratory has earlier generated enhanced green fluorescent protein (EGFP)-expressing FVB/N transgenic ‘green’ mouse: GU-3 line (Devgan et al., 2003). This transgenic mouse has been an excellent source of intrinsically green fluorescent cell types. Recently, we have derived a ‘GS-2’ ES-cell line from the GU-3 mouse line (Singh et al., 2012). Additionally, we envisaged the need for developing an iPS-cell line from the GU-3 mouse and then use them for studying cell differentiation. Thus, aims of the study described in the thesis are to: (1) develop an experimental system to derive EGFP-expressing fluorescently-marked iPS-cell line from a genetically non-permissive FVB/N mouse strain, characterize the established iPS-cell line and achieve differentiation of various cell types from EGFP-expressing iPS-cell line; (2) to study differentiation phenomenon, in particular to cardiac lineage, using select-cardiogenesis modulators and (3) to assess the gene-expression profiles and signaling system associated with cardiomyocyte differentiation of PSCs. This thesis is divided into four chapters with the 1st chapter being a review of literature followed by three data chapters. In the chapter I of the thesis, a comprehensive up-to¬date review of literature is provided pertaining to PSCs, their classification, derivation strategies especially for reprogramming of somatic cells for iPSC generation, their differentiation potential and characterization, particularly to cardiac lineage. Various molecular regulators involved in cardiac differentiation of PSCs with emphasis on epigenetic regulation involving DNA methylation and signaling pathways involved are described in detail. Subsequently, various approaches used for enhanced cardiac differentiation of PSCs and the therapeutic potential of PSC-derived differentiated cell types to treat disease(s) are discussed. Chapter-II describes the successful establishment of a permanent iPS-cell line (named ‘N9’ iPS-cell line) from the non-permissive FVB/N EGFP-transgenic GU-3 ‘green’ mouse. This chapter provides results pertaining to detailed derivation strategy and characterization of the ‘N9’ iPS-cell line which includes colony morphology, expansion (proliferation) efficiency, alkaline phosphatase staining, pluripotent markers’ expression analysis by qPCR and immunostaining approaches and karyotyping analysis. Further, in order to thoroughly assess the differentiation competence of the ‘N9’ iPS¬cell line, assessment of in-vitro and in-vivo differentiation potential of the ‘N9’ iPS-cell line by embryoid body (EB) formation and teratoma formation in nude mice and its detailed histological analysis showing three germ layer cell types and their derivatives were performed, followed by the generation of chimeric blastocysts by aggregation method. This established N9 iPS-cell line could potentially offer a suitable model system to study cardiac differentiation along with other established PSC lines such as the GS-2 and D3 ES-cell lines and the P19 EC-cell line. Following the establishment of the system to study cardiac differentiation of PSC lines, efforts were made to understand the biology of cardiac differentiation of PSCs (wild¬type and EGFP-transgenic PSC lines and P19 EC-cell line) using small molecules as modulators. Data pertaining to this is described in Chapter-III. The possible involvement of epigenetic regulation of cardiogenesis for example, DNA methylation changes in cardiogenesis-associated genes is studied using 5-aza cytidine as one of the chromatin modifiers. In order to understand the cardiac differentiation phenomenon, as a consequence of using 5-aza cytidine in cell culture, it was important to investigate its ability to induce/mediate cardiac differentiation. This involved an assessment by quantitating the cardiac beating phenotype and correlating this with enhanced cardiac-gene expression profiles. Further, DNA methylation regulation of cardiogenesis¬associated genes is described using various DNA methylation analysis techniques. Moreover, the possible involvement of other signaling members in mediating the cardiac differentiation is also studied using the P19 EC-cells. Results pertaining to the above findings are described in detail in the Chapter-III. Chapter-IV is focused on various efforts made towards investigating the ability of ascorbic acid to enhance cardiac differentiation of mouse ES-cells (GS-2 and D3 lines). Ascorbic acid has been implicated to be influencing cardiogenesis and it is reported to enhance differentiation of various cell types under certain culture conditions. Results pertaining to enhancement of cardiac differentiation of PSCs using ascorbic acid are presented in this chapter. This included assessment by quantitating cardiac beating phenotype and its correlation with enhanced cardiogenesis-associated gene expression profiles. Besides, estimation on the sorted cardiomyocyte population, derived from PSCs was also made using mature-cardiac marker. The possible underlying signaling mechanism involved was also studied in detail, using specific inhibitors for pERK (U0126), integrin signaling (pFAK; PP2) and collagen synthesis (DHP), in order to ascertain their involvement in ascorbic acid-mediated cardiac differentiation of mouse ES-cells. Subsequent to the three data chapters (II-IV), separate sections are provided for ‘Summary and Conclusion’ and for ‘Bibliography’, cited in the thesis. The overall scope of the study has been to understand the basic biology of cardiac differentiation from PSCs (EC-cells, iPS-cells and transgenic and wild-type ES-cells) and to assess, by using certain small molecules, whether PSCs could be coaxed to enhance the differentiation to a particular cell type (cardiac). The data contained in this thesis addresses the above theme.

No description available.

No description available.